Swift Accel-Amplicon™ 57G Pan-Cancer Profiling Panel by Swift Biosciences, Inc

The Accel-Amplicon Plus 57G Pan-Cancer Profiling Panel is a great starting point for any cancer sequencing project. The 57G Pan-Cancer Panel builds off our previous 56G Oncology Panel, and offers much more. At its core, the panel offers comprehensive and hotspot coverage of 57 clinically-relevant oncology-related genes implicated in both solid tumors and hematological cancers. It is flexible too, allowing you to stack modules of content to achieve your most optimal design. Either choose from our pre-validated content, such as BRCA1, BRCA2, EGFR, etc. or add your own targets. We’ll work alongside you to design your assay and then we will optimize and wet-bench validate its performance before shipping to you.

Key features include: 

• Robust performance on cell-free DNA and FFPE samples starting with as little as 10 ng input
• Sensitive detection of rare variants down to 1% allele frequency
• Easy, single-tube assay with sequence ready libraries in 2 hours
• Streamlined analysis with new bioinformatics tools including Primerclip or Genialis
• Compatible with all Illumina sequencers